Sensus Healthcare (NASDAQ:SRTS) Trading Up 5.1%

Sensus Healthcare, Inc. (NASDAQ:SRTS)’s share price rose 5.1% during mid-day trading on Monday . The stock traded as high as $5.94 and last traded at $5.80. Approximately 191,371 shares changed hands during trading, a decline of 40% from the average daily volume of 318,686 shares. The stock had previously closed at $5.52.

Analyst Ratings Changes

Several research firms have recently weighed in on SRTS. Roth Capital raised shares of Sensus Healthcare to a “strong-buy” rating in a report on Friday, July 12th. HC Wainwright reaffirmed a “buy” rating and set a $10.00 price objective on shares of Sensus Healthcare in a research note on Monday, August 12th.

Sensus Healthcare Price Performance

The business has a 50 day simple moving average of $6.15 and a 200 day simple moving average of $5.05. The company has a market cap of $95.06 million, a price-to-earnings ratio of 20.00 and a beta of 1.05.

Sensus Healthcare (NASDAQ:SRTS) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.07. Sensus Healthcare had a return on equity of 13.46% and a net margin of 18.27%. The business had revenue of $9.24 million during the quarter, compared to analysts’ expectations of $7.00 million. During the same period in the previous year, the business posted ($0.02) earnings per share. As a group, sell-side analysts anticipate that Sensus Healthcare, Inc. will post 0.36 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of SRTS. Chapin Davis Inc. acquired a new stake in Sensus Healthcare in the second quarter worth about $53,000. XTX Topco Ltd bought a new position in shares of Sensus Healthcare in the 2nd quarter valued at about $95,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Sensus Healthcare during the 2nd quarter worth approximately $156,000. Creekmur Asset Management LLC bought a new stake in shares of Sensus Healthcare during the fourth quarter worth approximately $83,000. Finally, Hillsdale Investment Management Inc. bought a new stake in shares of Sensus Healthcare during the first quarter worth approximately $155,000. Institutional investors own 25.30% of the company’s stock.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.